ABOUT THE AUTHOR

Kevin Musni

Kevin Musni
Kevin has more than 8 years of professional experience focusing on general and real estate accounting, budget and cash flow analyses, and financial modeling. His expertise is on business process optimization, systems migration, and developing reasonable business policies. He is adept at utilizing multiple reporting software and other SaaS interfaces. He currently manages a mixture of Real Estate and Biotechnology groups in Scrubbed. Prior to Scrubbed, he worked at the Fraud, Claims, and Disputes Unit of JPMorgan Chase & Co.

Content

Scaling Financial Operations in Life Sciences & Biotech with Fractional Teams

Life sciences and biotech companies are increasingly seeing challenges in funding, resource management and compliance that affect their ability to succeed. In a recent webinar co-hosted by California Life Sciences and Scrubbed, our expert panel shared their insights on what is shaping financials in life sciences and biotech and how a fractional finance and accounting model can help firms grow without sacrificing quality or compliance.

From R&D to ROI: How Outsourced Accounting Fuels Biotech Innovation

Unlock biotech innovation potential with outsourced accounting. Transform R&D investments into ROI drivers. Streamline financial processes efficiently.

Streamlining for Growth: Simplifying Account and Financial Processes in Biotech

Unlock biotech success with streamlined account and financial processes. Our solutions simplify complexities, fostering growth. Explore efficiency today.

5 Accounting FAQs on the Minds of Today’s Biotech Leaders

Navigating biotech's unique accounting challenges is crucial for success. Explore our Biotech Accounting FAQs for expert insights.